Thyroid Function Test Market by Type (TSH Tests, T4 Tests, T3 Tests), End User (Hospitals, Diagnostic Laboratories, Research Laboratories & Institutes), and Region (North America, Europe, APAC, LATAM, and MEA) - Global Forecast to 2022

甲状腺機能検査の世界市場予測(~2022年):タイプ別(TSH検査、T4検査、T3検査)、エンドユーザー別(病院、診断ラボ、研究ラボ・機関)、地域別(北米、ヨーロッパ、太平洋アジア、ラテンアメリカ、中東・アフリカ)

◆タイトル:Thyroid Function Test Market by Type (TSH Tests, T4 Tests, T3 Tests), End User (Hospitals, Diagnostic Laboratories, Research Laboratories & Institutes), and Region (North America, Europe, APAC, LATAM, and MEA) - Global Forecast to 2022
◆商品コード:MAM-BT-6032
◆調査・発行会社:MarketsandMarkets
◆発行日:2018年2月23日
◆ページ数:122
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名利用)USD5,650 ⇒換算¥638,450見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥751,450見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥920,950見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

MarketsandMarketsが発行した当調査レポートでは、甲状腺機能検査の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、甲状腺機能検査の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・市場概要
・甲状腺機能検査市場:タイプ別
・甲状腺機能検査市場:エンドユーザー別
・甲状腺機能検査市場:地域別
・競争状況
・企業プロファイル
・付録

“The thyroid function tests market is projected to grow at a CAGR of 5.9%.”
The global thyroid function tests market is projected to reach USD 1.68 billion by 2022 from an estimated USD 1.26 billion in 2017, at a CAGR of 5.9% during the forecast period. Growth in the market can primarily be attributed to factors such as increasing incidence of thyroid disorders, increasing awareness about thyroid disorders, increasing prevalence of lifestyle diseases, rising geriatric population, and increasing consumption of alcohol and tobacco. However, unfavorable healthcare reforms in the US are likely to restrain the growth of this market to a certain extent.
“The hospitals segment is projected to grow at the highest CAGR during the forecast period.”
By end user, the market is categorized into hospitals, diagnostic laboratories, research laboratories & institutes, and other end users. The hospitals segment is expected to grow at the highest CAGR during the forecast period. The high volume of thyroid function tests performed in hospital-based laboratories across the globe, growing patient population (and the subsequent increase in the number of clinical tests performed in hospitals), and growing number of public healthcare awareness campaigns organized by hospitals are some of the factors driving this market segment.
“Asia Pacific to witness the highest growth during the forecast period.”
The Asia Pacific market is expected to grow at the highest CAGR during the forecast period of 2017–2022. The high growth rate of this segment is attributed to the presence of a large geriatric population coupled with the universal healthcare reimbursement policy and a well-developed healthcare system in Japan.
The high burden of thyroid diseases, increasing disposable income of the middle-class population in China, presence of a large patient population, growing access to healthcare facilities, and improving healthcare infrastructure in India are some of the other major factors driving the growth of this regional segment.
Break of primary participants was as mentioned below:
 By Company Type: Tier I: 55%, Tier II: 25%, Tier III: 20%
 By Designation: C-Level Executives: 43%, Directors: 32%, Others: 25%
 By Region: North America: 33%, Europe: 31%, Asia Pacific: 20%, Latin America: 8%, Middle East & Africa: 8%
In 2017, Thermo Fisher (US), Abbott (US), Roche (Switzerland), DiaSorin (Italy), Danaher (US), Kronus (US), Merck (Germany), Cortez Diagnostics (US), bioMérieux (France), Qualigen (US), and Autobio Diagnostics (China) were the leading players in the thyroid function tests market.
Research Coverage
The report provides a picture of the market across different industry verticals and regions. It aims at estimating the market size and future growth potential of this market across different segments such as by type, end user, and region. Furthermore, the report also includes an in-depth competitive analysis of the key players in the market along with their company profiles, recent developments, and key market strategies.
Reasons to Buy the Report:
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn helps the firms to garner a greater share of the concerned market. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies to strengthening their market shares.
The report provides insights on the following pointers:
• Market Penetration: Comprehensive information on the product portfolios offered by the top players in the thyroid function tests market. The report analyzes the market by type, end user, and region.
• Product Development/Innovation: Detailed insights on the upcoming technologies, research & development activities, product enhancements, and new product launches in the thyroid function tests market
• Market Development: Comprehensive information about the lucrative emerging markets. The report analyzes the markets for various thyroid function tests across regions
• Market Diversification: Exhaustive information about new products, untapped regions, recent developments, and investments in the thyroid function tests market
• Competitive Assessment: In-depth assessment of the market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the thyroid function tests market

【レポートの目次】

TABLE OF CONTENTS

1 INTRODUCTION 13
1.1 OBJECTIVES OF THE STUDY 13
1.2 DEFINITION 13
1.3 MARKET SCOPE 14
1.3.1 MARKETS COVERED 14
1.3.2 YEARS CONSIDERED FOR THE STUDY 14
1.4 CURRENCY 15
1.5 LIMITATIONS 15
1.6 STAKEHOLDERS 15
2 RESEARCH METHODOLOGY 16
2.1 RESEARCH DATA 16
2.1.1 SECONDARY DATA 17
2.1.1.1 Secondary sources 18
2.1.2 PRIMARY DATA 19
2.1.2.1 Key data from primary sources 20
2.1.2.2 Breakdown of primaries 20
2.1.2.3 Key industry insights 21
2.2 MARKET SIZE ESTIMATION 21
2.3 MARKET BREAKDOWN AND DATA TRAINGULATION 23
2.4 ASSUMPTIONS FOR THE STUDY 24
3 EXECUTIVE SUMMARY 25
4 PREMIUM INSIGHTS 28
4.1 THYROID FUNCTION TESTS: MARKET OVERVIEW 28
4.2 ASIA PACIFIC: THYROID FUNCTION TESTS MARKET SHARE, BY TYPE AND COUNTRY 29
4.3 THYROID FUNCTION TESTS MARKET, BY TYPE 30
4.4 THYROID FUNCTION TESTS MARKET, BY END USER 30
4.5 GEOGRAPHIC SNAPSHOT OF THE THYROID FUNCTION TESTS MARKET 31
5 MARKET OVERVIEW 32
5.1 INTRODUCTION 32
5.2 MARKET DYNAMICS 32
5.2.1 DRIVERS 33
5.2.1.1 Increasing incidence of thyroid disorders 33
5.2.1.2 Increasing awareness about thyroid disorders 33
5.2.1.3 Increasing prevalence of lifestyle diseases and rising geriatric population 34
5.2.1.4 Increasing consumption of alcohol and tobacco 34
5.2.2 RESTRAINTS 35
5.2.2.1 Unfavorable healthcare reforms in the US 35
5.2.3 OPPORTUNITIES 35
5.2.3.1 Growth opportunities in emerging Asia Pacific countries 35
5.2.4 CHALLENGES 35
5.2.4.1 Fluctuations in the reference range for thyroid function tests 35
6 THYROID FUNCTION TESTS MARKET, BY TYPE 36
6.1 INTRODUCTION 37
6.2 TSH TESTS 38
6.3 T4 TESTS 39
6.4 T3 TESTS 41
6.5 OTHER TESTS 42
7 THYROID FUNCTION TESTS MARKET, BY END USER 45
7.1 INTRODUCTION 46
7.2 HOSPITALS 47
7.3 DIAGNOSTIC LABORATORIES 48
7.4 RESEARCH LABORATORIES AND INSTITUTES 49
7.5 OTHER END USERS 50
8 THYROID FUNCTION TESTS MARKET, BY REGION 51
8.1 INTRODUCTION 52
8.2 NORTH AMERICA 54
8.2.1 US 56
8.2.2 CANADA 57
8.3 EUROPE 58
8.3.1 GERMANY 61
8.3.2 FRANCE 62
8.3.3 UK 63
8.3.4 ITALY 64
8.3.5 SPAIN 66
8.3.6 RUSSIA 67
8.3.7 REST OF EUROPE 68
8.4 ASIA PACIFIC 70
8.4.1 JAPAN 72
8.4.2 CHINA 73
8.4.3 INDIA 75
8.4.4 REST OF ASIA PACIFIC 77

8.5 LATIN AMERICA 79
8.5.1 BRAZIL 81
8.5.2 MEXICO 82
8.5.3 REST OF LATIN AMERICA 83
8.6 MIDDLE EAST AND AFRICA 85
9 COMPETITIVE LANDSCAPE 87
9.1 OVERVIEW 87
9.2 RANKING OF PLAYERS AND INDUSTRY CONCENTRATION, 2016 88
9.3 COMPETITIVE SCENARIO 88
9.3.1 ACQUISITIONS 88
9.3.2 EXPANSIONS 89
9.3.3 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS 89
9.3.4 PRODUCT LAUNCHES AND ENHANCEMENTS 90
10 COMPANY PROFILES 91
10.1 ABBOTT 91
10.2 MERCK 94
10.3 THERMO FISHER 97
10.4 DANAHER 100
10.5 ROCHE 103
10.6 DIASORIN 105
10.7 BIOMÉRIEUX 107
10.8 DIAGNOSTIC AUTOMATION/CORTEZ DIAGNOSTICS 109
10.9 QUALIGEN 110
10.10 KRONUS 111
10.11 AUTOBIO DIAGNOSTICS 112
11 APPENDIX 113
11.1 DISCUSSION GUIDE 113
11.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 116
11.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 118
11.4 AVAILABLE CUSTOMIZATIONS 119
11.5 RELATED REPORTS 119
11.6 AUTHOR DETAILS 120

LIST OF TABLES

TABLE 1 THYROID FUNCTION TESTS MARKET, BY TYPE, 2015–2022 (USD MILLION) 37
TABLE 2 TSH TESTS MARKET, BY REGION, 2015–2022 (USD MILLION) 38
TABLE 3 TSH TESTS MARKET, BY COUNTRY, 2015–2022 (USD MILLION) 39
TABLE 4 T4 TESTS MARKET, BY REGION, 2015–2022 (USD MILLION) 40
TABLE 5 T4 TESTS MARKET, BY COUNTRY, 2015–2022 (USD MILLION) 40
TABLE 6 T3 TESTS MARKET, BY REGION, 2015–2022 (USD MILLION) 41
TABLE 7 T3 TESTS MARKET, BY COUNTRY, 2015–2022 (USD MILLION) 42
TABLE 8 OTHER THYROID FUNCTION TESTS MARKET, BY REGION,
2015–2022 (USD MILLION) 43
TABLE 9 OTHER THYROID FUNCTION TESTS MARKET, BY COUNTRY,
2015–2022 (USD MILLION) 44
TABLE 10 THYROID FUNCTION TESTS MARKET, BY END USER, 2015–2022 (USD MILLION) 46
TABLE 11 THYROID FUNCTION TESTS MARKET FOR HOSPITALS, BY REGION,
2015–2022 (USD MILLION) 48
TABLE 12 THYROID FUNCTION TESTS MARKET FOR DIAGNOSTIC LABORATORIES, BY REGION, 2015–2022 (USD MILLION) 48
TABLE 13 THYROID FUNCTION TESTS MARKET FOR RESEARCH LABORATORIES AND INSTITUTES, BY REGION, 2015–2022 (USD MILLION) 49
TABLE 14 THYROID FUNCTION TESTS MARKET FOR OTHER END USERS, BY REGION,
2015–2022 (USD MILLION) 50
TABLE 15 THYROID FUNCTION TESTS MARKET, BY REGION, 2015–2022 (USD MILLION) 53
TABLE 16 NORTH AMERICA: THYROID FUNCTION TESTS MARKET, BY COUNTRY,
2015–2022 (USD MILLION) 55
TABLE 17 NORTH AMERICA: THYROID FUNCTION TESTS MARKET, BY TYPE,
2015–2022 (USD MILLION) 55
TABLE 18 NORTH AMERICA: THYROID FUNCTION TESTS MARKET, BY END USER,
2015–2022 (USD MILLION) 56
TABLE 19 US: THYROID FUNCTION TESTS MARKET, BY TYPE, 2015–2022 (USD MILLION) 56
TABLE 20 US: THYROID FUNCTION TESTS MARKET, BY END USER,
2015–2022 (USD MILLION) 57
TABLE 21 CANADA: THYROID FUNCTION TESTS MARKET, BY TYPE,
2015–2022 (USD MILLION) 58
TABLE 22 CANADA: THYROID FUNCTION TESTS MARKET, BY END USER,
2015–2022 (USD MILLION) 58
TABLE 23 EUROPE: THYROID FUNCTION TESTS MARKET, BY COUNTRY,
2015–2022 (USD MILLION) 60
TABLE 24 EUROPE: THYROID FUNCTION TESTS MARKET, BY TYPE,
2015–2022 (USD MILLION) 60
TABLE 25 EUROPE: THYROID FUNCTION TESTS MARKET, BY END USER,
2015–2022 (USD MILLION) 61
TABLE 26 GERMANY: THYROID FUNCTION TESTS MARKET, BY TYPE,
2015–2022 (USD MILLION) 61
TABLE 27 GERMANY: THYROID FUNCTION TESTS MARKET, BY END USER,
2015–2022 (USD MILLION) 62
TABLE 28 FRANCE: THYROID FUNCTION TESTS MARKET, BY TYPE,
2015–2022 (USD MILLION) 63
TABLE 29 FRANCE: THYROID FUNCTION TESTS MARKET, BY END USER,
2015–2022 (USD MILLION) 63
TABLE 30 UK: THYROID FUNCTION TESTS MARKET, BY TYPE, 2015–2022 (USD MILLION) 64
TABLE 31 UK: THYROID FUNCTION TESTS MARKET, BY END USER,
2015–2022 (USD MILLION) 64
TABLE 32 ITALY: THYROID FUNCTION TESTS MARKET, BY TYPE, 2015–2022 (USD MILLION) 65
TABLE 33 ITALY: THYROID FUNCTION TESTS MARKET, BY END USER,
2015–2022 (USD MILLION) 65
TABLE 34 SPAIN: THYROID FUNCTION TESTS MARKET, BY TYPE, 2015–2022 (USD MILLION) 66
TABLE 35 SPAIN: THYROID FUNCTION TESTS MARKET, BY END USER,
2015–2022 (USD MILLION) 67
TABLE 36 RUSSIA: THYROID FUNCTION TESTS MARKET, BY TYPE, 2015–2022 (USD MILLION) 67
TABLE 37 RUSSIA: THYROID FUNCTION TESTS MARKET, BY END USER,
2015–2022 (USD MILLION) 68
TABLE 38 ROE: THYROID FUNCTION TESTS MARKET, BY TYPE, 2015–2022 (USD MILLION) 69
TABLE 39 ROE: THYROID FUNCTION TESTS MARKET, BY END USER,
2015–2022 (USD MILLION) 69
TABLE 40 ASIA PACIFIC: THYROID FUNCTION TESTS MARKET, BY COUNTRY,
2015–2022 (USD MILLION) 71
TABLE 41 ASIA PACIFIC: THYROID FUNCTION TESTS MARKET, BY TYPE,
2015–2022 (USD MILLION) 71
TABLE 42 ASIA PACIFIC: THYROID FUNCTION TESTS MARKET, BY END USER,
2015–2022 (USD MILLION) 72
TABLE 43 JAPAN: THYROID FUNCTION TESTS MARKET, BY TYPE, 2015–2022 (USD MILLION) 73
TABLE 44 JAPAN: THYROID FUNCTION TESTS MARKET, BY END USER,
2015–2022 (USD MILLION) 73
TABLE 45 CHINA: THYROID FUNCTION TESTS MARKET, BY TYPE, 2015–2022 (USD MILLION) 75
TABLE 46 CHINA : THYROID FUNCTION TESTS MARKET, BY END USER,
2015–2022 (USD MILLION) 75
TABLE 47 INDIA: THYROID FUNCTION TESTS MARKET, BY TYPE, 2015–2022 (USD MILLION) 76
TABLE 48 INDIA: THYROID FUNCTION TESTS MARKET, BY END USER,
2015–2022 (USD MILLION) 76
TABLE 49 ROAPAC: THYROID FUNCTION TESTS MARKET, BY TYPE,
2015–2022 (USD MILLION) 77
TABLE 50 ROAPAC: THYROID FUNCTION TESTS MARKET, BY END USER,
2015–2022 (USD MILLION) 78
TABLE 51 LATIN AMERICA: THYROID FUNCTION TESTS MARKET, BY COUNTRY,
2015–2022 (USD MILLION) 80
TABLE 52 LATIN AMERICA: THYROID FUNCTION TESTS MARKET, BY TYPE,
2015–2022 (USD MILLION) 80
TABLE 53 LATIN AMERICA: THYROID FUNCTION TESTS MARKET, BY END USER,
2015–2022 (USD MILLION) 81
TABLE 54 BRAZIL: THYROID FUNCTION TESTS MARKET, BY TYPE, 2015–2022 (USD MILLION) 81
TABLE 55 BRAZIL: THYROID FUNCTION TESTS MARKET, BY END USER,
2015–2022 (USD MILLION) 82
TABLE 56 MEXICO: THYROID FUNCTION TESTS MARKET, BY TYPE,
2015–2022 (USD MILLION) 83
TABLE 57 MEXICO: THYROID FUNCTION TESTS MARKET, BY END USER,
2015–2022 (USD MILLION) 83
TABLE 58 ROLA: THYROID FUNCTION TESTS MARKET, BY TYPE, 2015–2022 (USD MILLION) 84
TABLE 59 ROLA: THYROID FUNCTION TESTS MARKET, BY END USER,
2015–2022 (USD MILLION) 84
TABLE 60 MIDDLE EAST AND AFRICA: THYROID FUNCTION TESTS MARKET, BY TYPE,
2015–2022 (USD MILLION) 85
TABLE 61 MIDDLE EAST AND AFRICA: THYROID FUNCTION TESTS MARKET, BY END USER, 2015–2022 (USD MILLION) 86
TABLE 62 ACQUISITIONS (2014–2017) 88
TABLE 63 EXPANSIONS (2014–2017) 89
TABLE 64 AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS (2014–2017) 89
TABLE 65 PRODUCT LAUNCHES (2014–2017) 90


LIST OF FIGURES

FIGURE 1 RESEARCH METHODOLOGY: GLOBAL THYROID FUNCTION TESTS MARKET 16
FIGURE 2 RESEARCH DESIGN 17
FIGURE 3 SAMPLING FRAME: PRIMARY RESEARCH 19
FIGURE 4 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH 22
FIGURE 5 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 22
FIGURE 6 DATA TRIANGULATION METHODOLOGY 23
FIGURE 7 GLOBAL THYROID FUNCTION TESTS MARKET, BY TYPE, 2017 VS. 2022 25
FIGURE 8 GLOBAL THYROID FUNCTION TESTS MARKET, BY END USER, 2017 VS. 2022 26
FIGURE 9 ASIA PACIFIC TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD 27
FIGURE 10 INCREASING INCIDENCE OF THYROID DISORDERS DRIVING MARKET GROWTH 28
FIGURE 11 TSH TESTS SEGMENT TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA PACIFIC THYROID FUNCTION TESTS MARKET 29
FIGURE 12 TSH TESTS SEGMENT TO CONTINUE TO DOMINATE THE THYROID FUNCTION TESTS MARKET, BETWEEN 2017 AND 2022 30
FIGURE 13 HOSPITALS SEGMENT TO DOMINATE THE THYROID FUNCTION TESTS MARKET BETWEEN 2017 AND 2022 30
FIGURE 14 CHINA TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD 31
FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES, & CHALLENGES 32
FIGURE 16 TSH TESTS SEGMENT TO ACCOUNT FOR THE LARGEST SHARE OF THE THYROID FUNCTION TESTS MARKET IN 2017 37
FIGURE 17 HOSPITALS FORM THE LARGEST END-USER SEGMENT IN THE THYROID FUNCTION TESTS MARKET 46
FIGURE 18 THYROID FUNCTION TESTS: REGIONAL MARKET OVERVIEW 52
FIGURE 19 NORTH AMERICA: THYROID FUNCTION TESTS MARKET SNAPSHOT 54
FIGURE 20 EUROPE: THYROID FUNCTION TESTS MARKET SNAPSHOT 59
FIGURE 21 ASIA PACIFIC: THYROID FUNCTION TESTS MARKET SNAPSHOT 70
FIGURE 22 CHINA: DISPOSABLE INCOME PER CAPITA 74
FIGURE 23 LATIN AMERICA: THYROID FUNCTION TESTS MARKET SNAPSHOT 79
FIGURE 24 KEY DEVELOPMENTS IN THE THYROID FUNCTION TESTS MARKET BETWEEN 2014 AND 2017 87
FIGURE 25 ABBOTT LED THE THYROID FUNCTION TESTS MARKET IN 2016 88
FIGURE 26 ABBOTT: COMPANY SNAPSHOT (2016) 91
FIGURE 27 MERCK: COMPANY SNAPSHOT 94
FIGURE 28 THERMO FISHER: COMPANY SNAPSHOT 97
FIGURE 29 DANAHER: COMPANY SNAPSHOT 100
FIGURE 30 ROCHE : COMPANY SNAPSHOT 103
FIGURE 31 BIOMÉRIEUX: COMPANY SNAPSHOT 107


★調査レポート[甲状腺機能検査の世界市場予測(~2022年):タイプ別(TSH検査、T4検査、T3検査)、エンドユーザー別(病院、診断ラボ、研究ラボ・機関)、地域別(北米、ヨーロッパ、太平洋アジア、ラテンアメリカ、中東・アフリカ)] ( Thyroid Function Test Market by Type (TSH Tests, T4 Tests, T3 Tests), End User (Hospitals, Diagnostic Laboratories, Research Laboratories & Institutes), and Region (North America, Europe, APAC, LATAM, and MEA) - Global Forecast to 2022 / MAM-BT-6032) 販売に関する免責事項
[甲状腺機能検査の世界市場予測(~2022年):タイプ別(TSH検査、T4検査、T3検査)、エンドユーザー別(病院、診断ラボ、研究ラボ・機関)、地域別(北米、ヨーロッパ、太平洋アジア、ラテンアメリカ、中東・アフリカ)] ( Thyroid Function Test Market by Type (TSH Tests, T4 Tests, T3 Tests), End User (Hospitals, Diagnostic Laboratories, Research Laboratories & Institutes), and Region (North America, Europe, APAC, LATAM, and MEA) - Global Forecast to 2022 / MAM-BT-6032) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆